Your browser doesn't support javascript.
loading
Efficacy and safety of pegfilgrastim biosimilar MD-110 in patients with breast cancer receiving chemotherapy: Single-arm phase III.
Takano, Toshimi; Ito, Mitsuya; Kadoya, Takayuki; Osako, Tomofumi; Aruga, Tomoyuki; Masuda, Norikazu; Miyaki, Toshiko; Niikura, Naoki; Shimizu, Daisuke; Yokoyama, Yuichi; Watanabe, Manabu; Tomomitsu, Masato; Aogi, Kenjiro.
Afiliação
  • Takano T; Breast Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Ito M; Department of Breast Surgery, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
  • Kadoya T; Department of Breast Surgery, Hiroshima University Hospital, Hiroshima, Japan.
  • Osako T; Breast Center, Kumamoto Shinto General Hospital, Kumamoto, Japan.
  • Aruga T; Department of Breast Surgery, Tokyo Metropolitan Center and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Masuda N; Department of Surgery, Breast Oncology, National Hospital Organization Osaka National Hospital, Osaka, Japan.
  • Miyaki T; Department of Breast Surgery, Chiba Cancer Center, Chiba, Japan.
  • Niikura N; Department of Breast Oncology, Tokai University Hospital, Isehara, Japan.
  • Shimizu D; Breast Center, Yokohama City Minato Red Cross Hospital, Yokohama, Japan.
  • Yokoyama Y; Mochida Pharmaceutical Co., Ltd., Tokyo, Japan.
  • Watanabe M; Mochida Pharmaceutical Co., Ltd., Tokyo, Japan.
  • Tomomitsu M; Mochida Pharmaceutical Co., Ltd., Tokyo, Japan.
  • Aogi K; Department of Breast Surgery, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
Cancer Med ; 12(20): 20242-20250, 2023 10.
Article em En | MEDLINE | ID: mdl-37824431

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Medicamentos Biossimilares / Neutropenia Limite: Female / Humans Idioma: En Revista: Cancer Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Medicamentos Biossimilares / Neutropenia Limite: Female / Humans Idioma: En Revista: Cancer Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão